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There are so many things we do as part of our profession that are never purposely 29 taught during our training. These activities simply are not part of our curriculum. Yet there is 30
frequently an assumption that if we excel at performing surgery all these other tasks will also 31 be performed at a high level. Things like billing, preparing talks, giving feedback, leadership 32 skills and reviewing a paper are just a few examples where we assume competence is 33 extrapolated from our achievement of competence in clinical care. 34
Alas, the truth is that these activities are skills and like any skill they must be mastered 35 independently. Being a skillful surgeon does not automatically grant the same level of skill in 36 other domains. Dr's Nason and colleagues have directly addressed one of these example, the 37 ability to perform a meaningful peer review. While this is not a systematic review of the 38 literature (very little if any literature exists) it does provide a clear and complete framework on 39 what constitutes, in these authors mind, an efficient and consequential review. As an editor 40 their description, if even adhered to by only a majority of reviewers, would greatly improve the 41 quality of peer review. 42 If we, as a profession, are intent on advancing our field and remaining relevant then 43 high quality peer review of our scientific work is mandatory. Dr Nason and colleagues have 44 provided a framework for the process but to truly be effective we must engage broad 45 representation of our profession. Providing peer review is not the exclusive purview of the 46 academics who provide the manuscripts. To truly reflect the knowledge within our profession 47 the peer review process must include a generalizable representation of those who engage in 48 our profession. This work by Dr Nason et al provides the tools to achieve that end. 49 50 51 52 M A N U S C R I P T
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Journal editors rely on peer review from physicians, biomedical researchers, and 53 biostatisticians to critically examine study aims, design, and methodology, and ensure that 54 analyses and conclusions are accurate prior to manuscript publication. Given the importance of 55 this process and clinician reliance on the published literature to guide clinical practice, we sought 56 to provide peer reviewers guidance and a rubric for performing optimal reviews. 57
The Editorial Process 58
Following submission, the journal's editor selects peer reviewers, emails invitations and 59 uses the feedback to guide publication decisions. Journals set deadlines for reviewers to: 1) 60 respond to the invitation and 2) submit the review. A prompt response from reviewers is vital to 61 moving the process forward. If the reviewer has a conflict of interest, s/he should decline the 62 review and has the opportunity to state the reason for doing so. The peer reviewer is expected to 63 make recommendations to the editor, based on his or her comprehensive assessment of the 64 manuscript, as to acceptability for publication.
1-3 A thorough review can take approximately 65 three hours, but varies with experience.
1,3 Exceptional reviews provide the editor and author(s) 66 clear, concise, insightful and constructive feedback, which accurately reflect manuscript 67 strengths and weaknesses. They also provide specific recommendations for revisions that should 68 significantly improve the manuscript. The following provides a step-by-step approach to optimal 69 review of scientific manuscripts (Table 1) . 70
Title Page 71
The title, author list, institutional affiliations, prior presentation of the data and corresponding 72 author are universal components of the title page and should accurately and truthfully represent 73 the contributions to the manuscript and the responsible parties. The title is an often overlooked 74 but critical feature of each manuscript. An informative, compelling title will entice readers intoM A N U S C R I P T
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reading the paper whereas a bland or nondescript title may cause readers to skip over an 76 otherwise excellent paper. The reviewer may guide authors to revise the title to descriptively 77 capture the essence of the paper. Each journal has instructions for authors that provide guidelines 78 regarding the required elements for the title page, including the number of words or characters 79 allowed in the title and other details. These journal-specific instructions should be familiar to the 80 reviewer and followed by the authors. Additional information may be requested on the title page, 81 including statements of author contributions, conflicts of interest, word count, key words, 82 acknowledgement of funding sources, and central or perspective messages. If these are 83 incorrectly presented or missing, instructions to the authors to correct the errors will reduce time 84
to publication by correcting them early in the revision process. 85
Abstract 86
The abstract provides the authors with an opportunity to summarize the objectives, methods, 87 results and conclusions for the journal readers. It is oftentimes the first, and perhaps only, section 88 of the manuscript that will be read as it is typically freely available through reference databases. 89
The abstract should provide a clear statement of the study objectives, which must match what is 90 stated in the introduction and other summary statements regarding the study. This is oftentimes 91 not the case and the astute reviewer will identify the discrepancy for the authors to correct. While 92 brief in length, the abstract methods must define the study group, stratification variables if any, 93
and provide a general overview of the analysis plan. The results should provide data that directly 94 address the stated objectives and support the abstract conclusions. Conclusions which are not 95 directly supported by the data provided in the abstract results should not be included in the 96 abstract; these conclusions belong in the manuscript discussion or the appropriate data added to 97 the abstract results. It is often the case that the abstract is excessively wordy without addedM A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT meaning. Authors often reply to reviewers that the word count restricts the information that can
Introduction 102
The introduction succinctly defines the scope of the problem and justification for further 103 investigation. 4 It should be no more than 2-3 paragraphs. Unfortunately, many authors attempt to 104 'set the stage' with extraneous information not germane to the study hypothesis or aims, such as 105 global statements about topics (epidemiology, survival, treatment) that are relevant to the disease 106
but not under investigation in the current study. When this is encountered, valuable reviews 107 provide authors constructive feedback to revise and limit the introduction to a brief statement on 108 the scope, importance and context of the problem relevant to and congruent with the specific 109 research question. The strengths and limitations of prior relevant studies are briefly introduced, 110 but in depth critique of them is reserved for the discussion section. The final paragraph of the 111 introduction is a clear statement of the study aim(s) and hypothesis. For studies focusing on 112 clinical questions, the aim should be testable and clearly identify the patient, population or 113 problem; the intervention, prognostic factor, or exposure of interest; the comparison groups or 114 alternative intervention; and the outcome to be evaluated. Often when the methods, results, and 115 discussion are confusing, it is because the study lacks clearly stated and testable aim(s). 116
Methods 117
The methods describe how the study aim(s) were tested and include the elements below. 118 Effective reviews provide authors feedback when these requirements are not met, including 119 sufficient information for each element such that independent investigators could replicate the 120 study.
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1) Type of research study and study participants: This includes type of study (Table 2) , 122 population, study setting, detailed inclusion and exclusion criteria and study time-123 frame/dates. 5 Critical evaluation of the appropriateness of the study design is a central 124 feature of an outstanding review. It is important to query whether the design allows for 125 the question(s) to be answered and whether the numbers of patients are sufficient. The 126 reviewer will assess whether the inclusion and exclusion criteria are justified and allow 127 for the study question to be evaluated. 128
2) Reporting Guidelines: Reporting guidelines by study type are available and useful to 129 both authors and reviewers as a checklist to ensure that all key elements of a study are 130 included in the manuscript. 6 (Table 3) For example, all clinical trials must have an 131 accompanying CONSORT flow diagram that demonstrates the progress through the 132 phases of a randomized clinical trial involving two groups.
7 These phases include 133 enrollment, intervention allocation, follow-up, and data-analysis. The reviewer will 134 assess these diagrams to make sure that the published protocol has not significantly 135 deviated from the intended trial protocol. 136
3) Data source: The data source and methods for data collection should be succinctly but 137 accurately described and referenced, including whether the data were prospectively 138 versus retrospectively collected, who collected the data, and whether the data abstractors 139 were blind to the study question or intervention. 140 4) Predictor variables: Any novel, complex or key study predictor variables should be 141 defined in detail, including how they were calculated and/or measured. As with the studyM A N U S C R I P T
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5) Outcomes:
The primary and secondary study outcome(s) should be stated and clearly 145 defined, consistent with the published literature. Examples of outcomes often 146 inadequately defined include survival outcomes; studies will often provide an 'end date' 147 for the study outcome, which is not linked to known patient status. This is incorrect and 148
should not be accepted. For overall survival, the 'end date' is patient-specific: it is the 149 date of death or the last date the patient was known to be alive. Unless the investigator 150 contacted all patients on the specified study 'end date' and confirmed alive status (highly 151 unlikely), a thorough review will identify the data definition error and recommend that 152 the data be reanalyzed, censoring alive patients on the date that they were confirmed 153
alive. Similar problems exist for disease-free survival analysis. Finally, another common 154 error encountered occurs when analyzing outcomes where the endpoint may not be 155 known precisely (for example, freedom from structural valve deterioration (SVD)). 156
Unless the definition of SVD is defined by echocardiographic criteria (gradients or 157 degree of regurgitation) and the date of the echocardiogram is ascertained, an actuarial 158 analysis may be flawed. While a reviewer may not know how to correct each problem, 159 alerting the editor to such issues will facilitate additional input from reviewers with 160 focused expertise. 161 6) Statistical Analyses: Outstanding reviewers understand that statistical tests performed 162
should be appropriate for the study question and the data being analyzed. 8 As with 163 variable definitions, sufficient detail is required such that an independent investigator 164 could replicate the analysis. Reproducibility of methodology and results is an area of 165 priority for the National Institutes of Health, and reviewers should ensure that the 166 descriptions provided are adequate and feasible to account for the results. 
ideally includes a biostatistician who was responsible for the analysis and involved in the 178 conception and execution of the study methodology. Increasingly, the involvement of a 179 biostatistician is a requirement of many manuscripts that utilize anything more than a 180 descriptive analysis. 181
7) Institutional Review Board (IRB): A statement of IRB approval or exemption and 182
informed consent (if indicated) is required and placed in the paragraph on study design or 183 in the statistical analysis section. Even systematic literature reviews, meta-analyses, and 184 secondary analysis of de-identified datasets require a statement that the study was 185 reviewed by the IRB and found to be exempt. 186
Results
187
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
section; the findings are presented objectively allowing the reader to draw his/her own 190
conclusions. 191
As a rule, the first paragraph summarizes the study population and highlights differences 192 Meier curves and actuarial curves, are often missing important components, including periodic 226 display of the confidence limits surrounding the data points, censoring events, and the number of 227 patients at risk at each time point. These components are necessary to understand the data and 228 meticulous reviewers advise the authors to include them in the manuscript revision. 229
Discussion 230
The discussion section allows the authors to explain the study importance to the reader, 231 and to provide clinical perspective and context. As a general rule, the first paragraph should 232 summarize the study hypothesis, aims and key findings. Subsequent paragraphs can be used to 233 discuss any relevant published data. In particular, discrepant studies should be referenced and the 234 A paragraph describing the study limitations is also mandatory. This paragraph typically 238 begins with a statement of the study strengths and then proceeds with a detailed list of the 239 limitations of the data and the analysis to address the study question(s). The authors should 240 indicate if, and how, they were able to overcome the limitations and whether or not the study is 241 generalizable. If the study is not generalizable, the populations to which the study applies should 242 be stated. Any limits to data interpretation should be noted. 243
The final paragraph reiterates the main study finding(s), concludes with the central 244 inferences for the reader, and denotes where future research might be focused. These inferences 245 include relevance of the study findings to the reader's clinical practice indicating why the study 246 findings are relevant to their practice and how s/he might implement the recommended changes. 247
Submitting your recommendations 248
Efficient reviewers are timely in submitting their recommendations and candid about 249 telling editors and authors what is great (or not) about the manuscript. Constructive and specific 250 feedback is key. Reviews that are too critical or inconsistent are of limited value, as are reviews 251 that are superficial and do not suggest opportunities for improvement. Reviewers are typically 252 asked several questions about the scientific value, originality, and analytic rigor of the study, and 253 whether biostatistical review is needed. Most journals offer three categories of recommendations: 254 1) Accept as is; 2) Revision and Re-review; and 3) Reject. Manuscripts are rarely accepted as is; 255 insightful reviewers can always offer the authors suggestions to strengthen a manuscript. Major 256 and uncorrectable flaws with the study design, inadequately powered studies or unsurmountable 257 problems with study definitions or outcomes are potential reasons for rejection.
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Most editorial sites include a 'Comments to Editor' section; reviewers are encouraged to 259 use this section to explain their recommendation to the editor. These 'Comments' should reflect 260 a clear understanding and accurate critique of study strengths and weaknesses. Statements should 261 not be arbitrary or unsupported; they should provide the editor unbiased and objective 262 justification for the recommendation. 263
Tips for improving the quality of your review 264
It is common for reviewers to focus their review on the introduction and the conclusions, 265 assuming that the authors have designed and executed a study that is appropriate for the study 266 question. Many times, however, this is not the case and a more critical appraisal identifies 267 opportunities for major improvements in the manuscript. In particular, many reviewers shy away 268 from analysis of the study methodology because of lack of expertise. There are several ways for 269 reviewers to improve their ability to critique study design and to determine whether the analysis 270 and presentation of results is appropriate for the study question. and other resources to research statistical tests reported in each study. 278
3) Most journals provide access to other reviewer comments; it is very instructive to review 279 other reviewer comments for the same manuscript after submitting your own review. The 280 good reviews and the bad reviews are equally valuable. The good reviews will provideM A N U S C R I P T
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detailed critiques on study design, analysis, presentation of results, as detailed above 282 while the bad ones will provide little to aid the editors in their decisions and the authors 283 in manuscript revisions. 284 4) Journals often provide feedback and ratings for reviewers based on timeliness and quality 285 of reviews. 286 5) Collaborate with a biostatistician when writing your own papers and engage in 287 discussions about accurate study design and analysis. 288 6) Investigate opportunities to earn continuing medical education credits for peer-review 289 activities, as some journals now offer this. 290
By approaching editorial reviewing as a constant learning process, reviewers develop and 291 improve with each opportunity to engage in the editorial process. 292
Conclusions 293
Consumers of medical literature expect peer-reviewed publications to be accurate, 294 meaningful, and ideally have high impact. Meeting this expectation requires a thorough and 295 critical evaluation of submitted manuscripts through the peer review process. An effective peer 296 review system will facilitate informed and sound clinical practice changes that will enhance 297 value-based care for our patients and iteratively educate the entire field of cardiothoracic surgery. 
Cohort study
Retrospective Cohort is assembled and data is abstracted after the primary outcome has already occurred Prospective Cohort is assembled and followed prospectively until the primary outcome occurs
Case-control study Identify those with and without the primary outcome to determine whether there is a difference in predictors between the two groups Descriptive Cross-sectional Analyzing data from a cohort at a particular point in time
Case series Description of a cohort of patients with the same disease or exposure; in surgical series, typically an operation Case report A detailed report of the signs, symptoms, diagnosis, treatment, and follow-up of one patient
Experimental Studies
Randomized Clinical Trial Comparison between two groups where each subject has an equal chance of being assigned to either the intervention or control arm
Secondary Clinical Research
Meta-analysis Statistical analysis of similar research studies to determine pooled estimates of the outcomes of interest
Systematic Review
Comprehensive and reproducible review of the literature regarding the research question, followed by statistical analysis, typically a meta-analysis, to determine pooled estimates of the outcomes of Interest M A N U S C R I P T 
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